Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenyang Yongda Pharmaceutical is a Chinese pharmaceutical company based in Shenyang, Liaoning Province, specializing in the research, development, and manufacturing of finished dosage forms. The company focuses primarily on gastrointestinal treatments, anti-infectives, and cardiovascular medications, with a strong emphasis on high-quality generic drugs. Its product portfolio includes well-known treatments such as Omeprazole and Famotidine, serving the domestic Chinese healthcare market. Shenyang Yongda operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to ensure product safety and efficacy. The company maintains a significant presence in the regional hospital and retail pharmacy sectors through its established distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenyang Yongda Pharmaceutical.